Endocrinology & metabolism

August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS20
Academic Journal
Presents an abstract of the research manuscript `Exaggerated free alpha-subunit (FAS) levels during pulsatile GnRH replacement in women with idiopathic hypogonadotropic hypogonadism (IHH),' by H.B. Lavoie, K.A. Martin et al from the Massachusetts General Hospital. Gonadotropin releasing hormone (GnRH).


Related Articles

  • Long-Term Administration of Gonadotropin-Releasing Hormone in Men with Idiopathic Hypogonadotropic Hypogonadism. Spratt, Daniel I.; Finkelstein, Joel S.; O'Dea, Louis St. L.; Badger, Thomas M.; Rao, Narasimha; Campbell, Jam D.; Crowley, William F. // Annals of Internal Medicine;Dec86, Vol. 105 Issue 6, p848 

    Studies effect of long-term administration of gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypognadism. Deficiency in gonadotropin-releasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism; Methodology of the study; Discussion on the result of...

  • Clomiphene Citrate Treatment May Be Effective.  // Fertility Weekly;12/11/2006, p4 

    The article discusses a study that aims to determine the treatment for hypogondotropic hypogonadism (HH) deficiency with clomiphene citrate (CC). The study was conducted among men who underwent physical examinations, including semen analysis and endocrine testing. From the results, it was found...

  • Lack of biochemical hypogonadism in elderly Arab males with low bone mineral density disease. Al Attia, Haider M.; Jaysundaram, Krishnasamy; Saraj, Fouad // Rheumatology International;Jan2010, Vol. 30 Issue 3, p365 

    The aim of the study is to study the relationship between androgen levels and bone mineral density (BMD) in elderly Arab males. Forty-five elderly Arab males underwent Dual X-ray absorptiometry for measurement of BMD. The outcomes were defined as per WHO description. Assays for testosterone (T),...

  • Current Gonadotropin Therapy is Not Optimal for These Men.  // Fertility Weekly;12/17/2012, p5 

    The article focuses on a study conducted by the researchers in New Zealand suggesting that the existing gonadotropin therapy is not the optimal treatment for men with congenital hypogonadotropic hypogonadism. Hypogonadotropic hypogonadism is a rare disorder described by decreased levels of...

  • Therapeutic Applications of Luteinizing-Hormone-Releasing Hormone and Its Analogs. Cutler Jr., Gordon B.; Hoffman, Andrew R.; Swerdloff, Ronald S.; Santen, Richard J.; Meldrum, David R.; Comite, Florence // Annals of Internal Medicine;May85, Vol. 102 Issue 5, p643 

    Presents information on a study which described the therapeutic applications of luteinizing-hormone-releasing hormone (LHRH) . History of LHRH; Fertility induction in hypothalamic hypogonadism; Induction of spermatogenesis; Ovulation induction; Hormonal control of spermatogenesis.

  • Molecular defects of the GNRH receptor gene in Chinese patients with idiopathic hypogonadotropic hypogonadism and the severity of hypogonadism. Fathi, Aws K.; Sicui Hu; Xi Fu; Shan Huang; Yan Liang; Xiaoping Luo // International Journal of Pediatric Endocrinology;2013, Vol. 2013 Issue Suppl 1, p1 

    An abstract of the study "Molecular Defects of the GNRH Receptor Gene in Chinese Patients With Idiopathic Hypogonadotropic Hypogonadism and the Severity of Hypogonadism" by Aws K. Fathi et al is presented.

  • Case Report Involving Isolated Hypogonadotropic Hypogonadism.  // Fertility Weekly;2/26/2007, p4 

    The article discusses the impact of partial loss-of-function mutations in the gonadotropin-releasing hormone (GnRH) receptor gene to puberty phenotypes. L. Lin and colleagues assert that mutations in the GnRH receptor like R262Q can exist with phenotypes such as delayed puberty. The study shows...

  • Phenotypic spectrum and hormonal profile in hypogonadotropic hypogonadism. Păun, D.; Gherlan, I.; Popescu, I.; Procopiuc, C.; Dumitrescu, C.; Brehar, A.; Dinu, D.; Neamtu, C.; Poiana, C.; Dumitrache, C. // Journal of Medicine & Life;Jan-Mar2014, Vol. 7 Issue 1, p42 

    Background: Hypogonadotropic hypogonadism (HH) is characterized by inappropriately low serum concentration of LH (luteinizing hormone) and FSH (follicle-stimulated hormone) in the setting of hypogonadism. A number of pathologic processes cause Hypogonadotropic hypogonadism but it can also occur...

  • Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women. Matta, W.H.; Shaw, R.W.; Hesp, R.; Katz, D. // British Medical Journal (Clinical Research Edition);6/13/1987, Vol. 294 Issue 6586, p1523 

    Examines the effects of luteinising hormone releasing hormone agonist analogues induced in hypogonadism of the bone density in premenopausal women. Use of luteinising hormone releasing hormone agonists in treating gynecological and non-gynecological conditions; Symptoms of using luteinising...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics